Global web ALERT button

COVID-19 Funding Opportunities - July 15

Jul 15, 2020, 10:08 AM by Melodi Moore

They Are Back!

FASTGrants

For the first call, which launched on April 7, FASTGrants committed to making decisions within 48 hours. They made more than 130 grants on this clock cycle. Several months later, many of the obvious projects are now underway, and the science has advanced to the point that deeper analysis of submissions will often prove valuable.

For this call, FASTGrants will always respond to submissions within 14 days (which remains faster than almost all other funding mechanisms), and will retain the flexibility to make immediate approvals where necessary.


IRONAID
A program of the IRONMAN Foundation, IRONAID will be supporting the following types of programs:
  • Providing personal, protective equipment (PPE) and for supplies such as ventilators, CT/x-ray machines, etc.
  • Supporting programs in the areas of housing/homelessness, healthcare, nutrition/food support, mental health, domestic violence, care for seniors, etc.
  • Finding ways to support quarantined individuals.
  • Funding organizations that are working in areas with poor access to regular medical services.
  • Supporting groups that are focused on WASH (Water, Sanitation and Hygiene).
  • Supporting the research into SARS-CoV-2 and COVID-19.
Deadline:  June 30, 2020

Gilead COMMIT RFP
(COvid-19 unMet MedIcal needs and associated research exTension)

The COMMIT program will support well defined individual projects of no more than $250,000 USD or equivalent sum; projects that are more than $250,000 will require approval by Gilead prior to submission.

Gilead will consider support for research proposals that meet one of the following criteria:

  • Expand data on clinical course and outcome in vulnerable populations:
    • Immune suppressed, specifically- HIV, cancer chronic inflammatory conditions (i.e., RA or IBD), and chronic liver disease, pre-existing pulmonary disease
    • Residents of long-term care facilities/nursing homes, and older adults
    • At risk for healthcare disparities (e.g.  Black/African American, socio-economic class)
  • Long-term sequelae (i.e., pulmonary fibrosis, neurologic, cardiac, quality of life)
  • Real world safety and effectiveness of remdesivir used alone or with other agents (JAK inhibitors, IL-6 inhibitors, convalescent plasma and ACE inhibitors and ARBs):
    • Viral kinetics and clinical outcomes
    • Based on duration of treatment (e.g., 5 vs 10 days, shorter courses)
    • Use in early (non-severe) disease
    • Course completion in alternative (non-inpatient setting) or alternative treatment pathways
Gilead will not consider proposals that request COVID-19 screening costs (including test kits) or proposals that requests remdesivir or other study drug.

LOI Deadline: Immediate - August 3, 2020


Russell Sage Foundation COVID-19 Social Science Grant

Now accepting applications for the following:

  1. Research on the Covid-19 pandemic and the resulting recession in the U.S. Specifically, research that assesses the social, political, economic, and psychological causes and consequences of the pandemic, especially its effects on marginalized individuals and groups and on trust in government and other institutions. Our priorities do not include analyses of health outcomes or health behavior.
  2. Research focused on systemic racial inequality and/or the recent mass protests in the U.S. Specifically, research that investigates the prevalence of racial disparities in policing and criminal justice and their social, political, economic, and psychological causes and consequences; the effects of the current social protest movement and mass mobilization against systemic discrimination; the nature of public attitudes and public policies regarding policing, criminal justice, and social welfare; and the effects of those attitudes in the current political environment.
Deadline: August 5

Robert Wood Johnson Foundation Supplemental Research on COVID-19 Response and Recovery

Eligible teams must have an active or recently completed research study (within 12 months of application submission) that can be extended through the use of supplemental research funding. This CFP is appropriate for studying an existing system alignment mechanism implemented prior to the arrival of the COVID-19 pandemic, and about which some pre-COVID evidence has already been created by the applicant. Studies funded through the S4A program must test a specific system alignment mechanism that engages all three of the sectors referenced in this call—medical care, public health, and social services.

Deadline: August 5

Genentech 2020 Diverse Future of STEM Fund: Kindergarten to Career

Genentech and The Genentech Foundation are accepting letters of interest from prospective partners working to build a more diverse and inclusive future of healthcare and science. From kindergarten to career, we partner with organizations that equip students with financial and
nonfinancial support, connect young professionals with mentors, and prepare young people to become leaders in science and medicine. We are excited to expand our work with new partners and will invite full proposals following our evaluation of the letters of interest.

Undergraduate and Graduate: Building Experience: Due to pre-existing inequities within our education system, the educational challenges posed by COVID-19 are having a disproportionate impact on BIPOC students. The Genentech Foundation is interested in funding programs that are responding to the challenges of COVID-19 and have a focus on BIPOC students, including (but not limited to):

  • Innovative wraparound programs that provide student support beyond tuition that address disruptions or additional challenges brought on by COVID-19 (i.e., student mental health support to address COVID-related trauma)
  • Bridge programming that ensures students continue their education and are prepared to be successful as undergraduates, particularly given the disruption to their K-12 education due to COVID-19
  • Capacity building for institutions trying to react and respond to the many challenges posed by COVID-19 while maintaining a Diversity, Equity & Inclusion strategy that supports BIPOC students, faculty, and employees
  • Programs that foster equitable environments that encourage experimentation and innovation for STEM faculty and leadership in light of changes to traditional educational models due to COVID-19
  • Strong proposals will align with the following high-level outcomes: 
    • Despite the challenges of COVID-19, there is an increase in BIPOC students entering and persisting in postsecondary education
    • Increase the number of faculty that are trained and have the necessary resources to successfully support BIPOC students in light of COVID-19
    • Increase institutional capacity to navigate the many challenges posed by COVID-19 with an equity lens, and foster environments where BIPOC students and faculty feel supported to succeed 

Postgraduate and Career Development: Representation of BIPOC in medicine and biomedical research are not reflective of the national population. Although Black and African American people represent 13% of the U.S. population, they make up less than four percent of practicing physicians. 1 BIPOC are also underrepresented in faculty and leadership positions in academia. Genentech is interested in funding innovative programs that support the career development, retention, and advancement of students and researchers working within Genentech’s therapeutic areas (see list below, additional priority will be placed on applications related to those listed in bold). Genentech is interested in supporting programs including (but not limited to):

  • Research awards for early- and mid-career researchers that identify as BIPOC
  • Mentorship awards for academic physicians, physician scientists or researchers that have a dedicated focus on leadership and advancement
  • Programs with curricula that support professional leadership development for BIPOC (i.e., skills building for self-advocacy, visibility, and negotiating leadership/advanced roles)
  • Strong proposals will align with the following high-level outcomes:
    •  Increase placement and retention of early- and mid-career researchers, academic physicians and physician scientists, particularly BIPOC
    • Expand the diversity of the national pool of qualified candidates for leadership roles in academic medicine and research
LOI Due:  August 10, 2020

Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health  

The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:

  • Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.
  • Data on the outcome of ongoing fertility care.
  • Data on gametes/embryos, fresh or frozen, from patients exposed to SARS-CoV-2.
  • Other information related to fertility outcomes

Ferring COVID-19 Investigational Grants will be awarded within 14 days of receipt from 15th April – 31st October 2020.

BARDA Broad Agency Announcement
Deadline: October 31, 2020

COVID-19 response related Areas of Interest includes:

  • AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms
  • AOI 7.7.2 Point-of-care diagnostic assay for detection of SARS-CoV-2 virus
  • AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), Including Serology Tests
  • [NEW] AOI 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
  • AOI 8.3 COVID-19 Vaccine
  • AOI 9.2 COVID-19 Therapeutics
  • AOI 10 Respiratory protective devices
  • AOI 17 Advanced Manufacturing Technologies

- - END- -